What's Happening?
Indigo Ag has introduced a new soybean bionematicide seed treatment called Biotrinsic Nemora FP, designed to combat soybean cyst nematode (SCN). This product, available for Spring planting, utilizes anti-hatch technology to manage nematode pressure while maintaining yield potential. Nemora FP is a microbial seed treatment that colonizes soybean roots and shoots, disrupting nematode hatch conditions. The treatment is based on the Pseudomonas oryzihabitans bacterium, which supports plant health and soil quality. According to Jon Giebel, VP North America Commercial-Biologicals at Indigo Ag, Nemora FP offers a biological alternative to chemical treatments, promoting sustainable agriculture practices.
Why It's Important?
Soybean cyst nematode is a significant threat to soybean production in the U.S. and Canada, causing substantial yield losses. The introduction of Nemora FP provides farmers with a sustainable management option that reduces reliance on chemical treatments. This aligns with broader agricultural trends towards environmentally friendly practices and could enhance soil health. The product's ability to reduce nematode hatch rates and support plant growth could lead to increased yields and profitability for farmers. Additionally, the use of biological treatments like Nemora FP can contribute to long-term agricultural sustainability and resilience against pest pressures.
What's Next?
Farmers interested in integrating Nemora FP into their planting plans for Spring 2026 are encouraged to contact Indigo Ag representatives. The company plans to continue promoting the benefits of biological seed treatments and may expand its product offerings in this area. As the agricultural industry increasingly focuses on sustainability, products like Nemora FP could become more prevalent, influencing farming practices and regulatory frameworks. Ongoing research and field trials will likely assess the long-term impacts of such treatments on crop yields and soil health.
